Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat
- PMID: 10657472
- DOI: 10.1054/npep.1999.0014
Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat
Abstract
Tachykinins like substance P (SP), neurokinin A (NKA), neurokinin B (NKB) differentially stimulate airway mucus secretion with the following rank order of potency in rat trachea: SP>NKA>NKB. These differential actions are most likely due to different affinities to the tachykinin receptors, termed neurokinin (NK)(1), NK(2)and NK(3). In this study we characterized the receptor subtype responsible for the differential secretagogue effects in rat trachea by means of selective receptor antagonists and receptor agonists.SR 140333 [NK(1)-antagonist] completely inhibited SP action (283,29+/-21, 12%-->84,53+/-4, 09%; P<0,01) and significantly reduced the effects of NKA (179,08+/-17,34%-->118,86+/-6,7%; P<0,01) and NKB (171,89+/-5, 75%-->109,5+/-4,11%; P<0,01). SR 48968 [NK(2)-antagonist] did not affect SP action, but reduced the effects of NKA and NKB. SR 142801 [NK(3)-antagonist] did not change any effect of SP, NKA or NKB. [Sar(9)]SP (NK(1)-agonist) caused strong dose-dependent secretagogue effects similar to SP, [betaAla(8)]NKA (NK(2)-agonist) showed only slight and [Pro(7)]NKB (NK(3)-agonist) no effects. The present data suggest that the secretagogue effects elicited by tachykinins in rat trachea are mediated via NK(1)receptors.
Copyright 1999 Harcourt Brace & Co. Ltd.
Similar articles
-
Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.Br J Pharmacol. 2000 Mar;129(6):1121-31. doi: 10.1038/sj.bjp.0703172. Br J Pharmacol. 2000. PMID: 10725260 Free PMC article.
-
Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.Br J Pharmacol. 1994 May;112(1):240-9. doi: 10.1111/j.1476-5381.1994.tb13058.x. Br J Pharmacol. 1994. PMID: 7518304 Free PMC article.
-
Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.Br J Pharmacol. 2000 Dec;131(7):1461-7. doi: 10.1038/sj.bjp.0703708. Br J Pharmacol. 2000. PMID: 11090121 Free PMC article.
-
Tachykinin NK2 antagonist for treatments of various disease states.Auton Neurosci. 2021 Nov;235:102865. doi: 10.1016/j.autneu.2021.102865. Epub 2021 Aug 2. Auton Neurosci. 2021. PMID: 34358844 Review.
-
Tachykinins in the gut. Part I. Expression, release and motor function.Pharmacol Ther. 1997;73(3):173-217. doi: 10.1016/s0163-7258(96)00195-7. Pharmacol Ther. 1997. PMID: 9175155 Review.
Cited by
-
Transcriptomic analysis of the temporal host response to skin infestation with the ectoparasitic mite Psoroptes ovis.BMC Genomics. 2010 Nov 10;11:624. doi: 10.1186/1471-2164-11-624. BMC Genomics. 2010. PMID: 21067579 Free PMC article.
-
Substance P stimulates CFTR-dependent fluid secretion by mouse tracheal submucosal glands.Pflugers Arch. 2008 Nov;457(2):529-37. doi: 10.1007/s00424-008-0527-0. Epub 2008 May 29. Pflugers Arch. 2008. PMID: 18509672
-
Effect of montelukast on platelet activating factor- and tachykinin induced mucus secretion in the rat.J Occup Med Toxicol. 2008 Feb 20;3:5. doi: 10.1186/1745-6673-3-5. J Occup Med Toxicol. 2008. PMID: 18289370 Free PMC article.
-
Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands.Br J Pharmacol. 2003 Jan;138(1):254-60. doi: 10.1038/sj.bjp.0705029. Br J Pharmacol. 2003. PMID: 12522097 Free PMC article.
-
Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).J Occup Med Toxicol. 2006 Jun 7;1:12. doi: 10.1186/1745-6673-1-12. J Occup Med Toxicol. 2006. PMID: 16759388 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous